Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spearhead Iomab-B Commercialization

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

Related Keywords

Caroline Yarbrough ,Bristol Myers Squibb ,Sandesh Seth ,Hans Vitzthum ,Lifesci Advisors ,Goizueta Business School At Emory University ,Merck Co ,University Of Delaware ,Nijenrode University ,Novartis ,International Business ,Peter White Undergraduate Research Fellowship ,Actinium Pharmaceuticals Inc ,Prnewswire Actinium Pharmaceuticals Inc ,Portfolio General Manager ,Glaxo Smithkline ,Chief Commercial ,Chief Executive ,Chief Business ,Goizueta Business School ,Emory University ,Pivotal Phase ,Complete Remission ,About Actinium Pharmaceuticals ,Elderly Relapsed ,Refractory Acute Myeloid Leukemia ,Sci Advisors ,Actinium Pharmaceuticals ,Nc ,